Virbac UK B2B
Latest news

Complimentary Oncology CPD for Vets & Nurses

To celebrate the launch of STELFONTA®, a breakthrough injectable solution to treat mast cell tumours in dogs, we are pleased to announce The STELFONTA ‘Seeing is Believing’ webinars; complimentary online CPD events for veterinary surgeons and veterinary nurses working in first opinion practice.

New Tramvetol® - Licensed Tramadol Tablets for Dogs

Virbac are pleased to announce the launch of Tramvetol®, licensed tramadol tablets for the treatment of acute and chronic pain in dogs.

New VETEMEX – The Sympathetic Antiemetic

Virbac is pleased to announce the launch of Vetemex, the new sympathetic antiemetic, for the treatment and prevention of vomiting and nausea in dogs and cats. With the active ingredient maropitant, a 56-day broached shelf life and a benzyl alcohol excipient, Vetemex boasts clear benefits for both veterinary surgeons and their patients.

New Kriptazen® - a clever twist in the fight against Cryptosporidiosis

Virbac is pleased to announce the launch of Kriptazen®, a non-antibiotic, halofuginone based cryptosporidiostatic medicine licensed for newborn calves, to prevent or reduce diarrhoea caused by Cryptosporidium parvum.

New BVA Guidance Recommends Medical Option as First Choice for Essential Neutering During Covid-19

Updated guidance from the British Veterinary Association (BVA) on neutering small animals during the COVID-19 pandemic, recommends that when neutering is considered essential within the next 2 months, medical options should be first considered.

Introducing Evicto

Virbac is pleased to announce the arrival of Evicto, the new Selamectin alternative for cats, dogs, kittens and puppies.